Concourse Financial Group Securities, Inc. Geron Corp Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$4.17 - $4.99 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$3.1 - $5.09 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$1.75 - $3.44 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$1.74 - $2.31 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$2.11 - $3.28 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$2.11 - $3.28 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$1.97 - $3.69 $0 - $0
Q1 2023 May 15, 2023	BUY	$2.14 - $3.4 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$2.03 - $2.42 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.67 - $2.94 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$1.19 - $1.65 $0 - $0
Q1 2022 May 09, 2022	BUY	$0.99 - $1.6 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$1.22 - $1.72 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$1.2 - $1.5 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$1.25 - $1.83 $0 - $0
Q1 2021 May 13, 2021	BUY	$1.52 - $2.1 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$1.55 - $2.05 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$1.59 - $2.19 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$1.05 - $2.18 $0 - $0
Q1 2020 May 13, 2020	BUY	$0.89 - $1.49 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$1.27 - $1.54 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$1.15 - $1.59 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$1.37 - $2.02 $0 - $0
Q1 2019 May 15, 2019	BUY	$1.01 - $1.83 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$0.98 - $1.85 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$1.76 - $6.38 $0 - $0

Others Institutions Holding GERN

# of Institutions

263

Shares Held

452M

Call Options Held

1.91M

Put Options Held

897K

Black Rock Inc. New York, NY

46.6M
Shares

$198 Million
0.0% of portfolio
Ra Capital Management, L.P. Boston, MA

46.2M
Shares

$196 Million
2.95% of portfolio
Vanguard Group Inc Valley Forge, PA

31.9M
Shares

$136 Million
0.0% of portfolio
Vivo Capital, LLC Palo Alto, CA

27.2M
Shares

$116 Million
17.06% of portfolio
Darwin Global Management, Ltd. St. Helier, Y9

23.9M
Shares

$102 Million
12.26% of portfolio

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.61B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account